Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Celecoxib for acute burn injury recovery
ACTRN12618000732280Phase 4Terminated
- Sponsor
- Fiona Stanley Hospital
- Start
- Jul 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in burn injury comparing Celecoxib plus standard care with Placebo plus standard care (2 arms). Primary endpoint: Scar quality by Patient Observer Scar Assessment Scale. Started Jul 2018; status: terminated.
02
Drugs
celecoxib
03
Conditions
burn injury
Beyond the preview
Go deeper on ACTRN12618000732280.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12618000732280.